Kejun Qi, Danqi Jia, Shengxi Zhou, Kun Zhang, Fangxia Guan, Minghao Yao, Xiaojie Sui
{"title":"Cryopreservation of Immune Cells: Recent Progress and Challenges Ahead.","authors":"Kejun Qi, Danqi Jia, Shengxi Zhou, Kun Zhang, Fangxia Guan, Minghao Yao, Xiaojie Sui","doi":"10.1002/adbi.202400201","DOIUrl":null,"url":null,"abstract":"<p><p>Cryopreservation of immune cells is considered as a key enabling technology for adoptive cellular immunotherapy. However, current immune cell cryopreservation technologies face the challenges with poor biocompatibility of cryoprotection materials, low efficiency, and impaired post-thaw function, limiting their clinical translation. This review briefly introduces the adoptive cellular immunotherapy and the approved immune cell-based products, which involve T cells, natural killer cells and etc. The cryodamage mechanisms to these immune cells during cryopreservation process are described, including ice formation related mechanical and osmotic injuries, cryoprotectant induced toxic injuries, and other biochemical injuries. Meanwhile, the recent advances in the cryopreservation medium and freeze-thaw protocol for several representative immune cell type are summarized. Furthermore, the remaining challenges regarding on the cryoprotection materials, freeze-thaw protocol, and post-thaw functionality evaluation of current cryopreservation technologies are discussed. Finally, the future perspectives are proposed toward advancing highly efficient cryopreservation of immune cells.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/adbi.202400201","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Cryopreservation of immune cells is considered as a key enabling technology for adoptive cellular immunotherapy. However, current immune cell cryopreservation technologies face the challenges with poor biocompatibility of cryoprotection materials, low efficiency, and impaired post-thaw function, limiting their clinical translation. This review briefly introduces the adoptive cellular immunotherapy and the approved immune cell-based products, which involve T cells, natural killer cells and etc. The cryodamage mechanisms to these immune cells during cryopreservation process are described, including ice formation related mechanical and osmotic injuries, cryoprotectant induced toxic injuries, and other biochemical injuries. Meanwhile, the recent advances in the cryopreservation medium and freeze-thaw protocol for several representative immune cell type are summarized. Furthermore, the remaining challenges regarding on the cryoprotection materials, freeze-thaw protocol, and post-thaw functionality evaluation of current cryopreservation technologies are discussed. Finally, the future perspectives are proposed toward advancing highly efficient cryopreservation of immune cells.
免疫细胞冷冻保存被认为是采用性细胞免疫疗法的一项关键技术。然而,目前的免疫细胞冷冻保存技术面临着冷冻保护材料生物相容性差、效率低、冻存后功能受损等挑战,限制了其临床转化。本综述简要介绍了采用性细胞免疫疗法和已获批准的免疫细胞产品,其中涉及 T 细胞、自然杀伤细胞等。文中介绍了这些免疫细胞在低温保存过程中的低温损伤机制,包括与冰形成相关的机械和渗透损伤、低温保护剂诱导的毒性损伤以及其他生化损伤。同时,还总结了针对几种代表性免疫细胞类型的冷冻保存介质和冻融方案的最新进展。此外,还讨论了当前冷冻保存技术在冷冻保护材料、冻融方案和冻融后功能评估方面仍面临的挑战。最后,提出了推进免疫细胞高效冷冻保存的未来展望。